• 18TH NOVEMBER 2022

    November 2022 Price Concessions 1st Update

    The Department of Health and Social Care (DHSC) has today (18/11/2022) granted the following initial list of price concessions for November 2022: Drug Pack size Price concession Amoxicillin 250mg/5ml oral suspension 100 £2.69 Amoxicillin 250mg/5ml oral suspension sugar free 100 £2.69 Benzydamine 0.15% mouthwash sugar free 300 £4.65 Bisacodyl 5mg gastro-resistant tablets 60 £4.99 Bisoprolol

    Read more
    • 17TH NOVEMBER 2022

    Autumn Statement: PSNC calls for investment in pharmacies

    The Chancellor of the Exchequer, Jeremy Hunt, has today (17th November) given his Autumn Statement, setting out Government spending plans. The Statement promises that the NHS budget will be increased in each of the next two years by £3.3bn, going some way towards meeting the request of NHS CEO Amanda Pritchard. But the Chancellor made

    Read more
    • 17TH NOVEMBER 2022

    PSNC hosts well attended parliamentary event

    On Tuesday 15th November PSNC hosted a parliamentary drop-in event for MPs and peers. The event lasted for two hours, during which MPs had the opportunity to drop-in and have their blood pressure measured by a pharmacists with experience of working on the front-line and were briefed on the urgent need for action to address

    Read more
    • 16TH NOVEMBER 2022

    Two SSPs issued for Estraderm® MX 50mcg and 75mcg patches

    In response to a significant ongoing disruption to the supply of Estraderm MX® 50mcg and 75mcg patches, two new Serious Shortage Protocols (SSPs) have been issued by the Department of Health and Social Care (DHSC). Effective 15 November 2022, SSP037 and SSP038 provides for the following: SSP037 – for every Estraderm MX® 50mcg  patch originally prescribed, one

    Read more
    • 16TH NOVEMBER 2022

    MHRA – Class 4 Medicines Defect Information: Venlafaxine XL 300 mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma)

    Class 4 Medicines Defect Information: Venlafaxine XL 300 mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma) Drug alert number: EL (22)A/47 Date issued: 16 November 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Venlafaxine XL 300 mg prolonged-release tablets, PL 01883/0363 Batch Number Expiry

    Read more
    • 16TH NOVEMBER 2022

    Two weeks left to complete mandatory workforce survey

    Community pharmacy contractors are reminded of the mandatory requirement to complete the 2022 Community Pharmacy Workforce Survey, managed by Health Education England (HEE), by 30th November 2022. Completion of the survey is a mandatory requirement for all contractors. The NHS Business Services Authority (NHSBSA) sent an email to contractors on 6th October 2022 containing a link to the

    Read more
    • 15TH NOVEMBER 2022

    Reminder: Packaged dose endorsement on prescriptions for methadone oral liquid

    When dispensing FP10MDA or FP10 prescriptions for methadone oral liquid, pharmacy contractors can claim packaged dose fees of £0.55 for each individual dose supplied in advance in daily dose containers. The number of packaged dose (‘PD’) fees to claim for is calculated as the total number of separately packaged doses given minus the number of

    Read more
    • 15TH NOVEMBER 2022

    PSNC launches new political influencing campaign

    PSNC is this week launching a new influencing campaign to build wider political support for community pharmacies and ensure that MPs and Peers across Parliament understand the risks to pharmacy services that the current pressures on the sector are causing. In a Parliamentary event to be held tomorrow (Tuesday 15th November) MPs and Peers will

    Read more
    • 14TH NOVEMBER 2022

    Mandatory national audit announced

    PSNC and NHS England have agreed that the 2022/23 national clinical audit will focus on valproate, with the aim of reducing the potential harm caused by taking valproate during pregnancy. The audit must be completed by all community pharmacy contractors as this is part of their NHS contractual requirements. Read the audit paperwork Contractors will be required to

    Read more
    • 14TH NOVEMBER 2022

    Survey suggests public lacks confidence to treat some common conditions

    More than half of people (52%) do not feel confident in treating backache and over a quarter of people (27%) would go to their GP or A&E for conditions that they could treat themselves at home, a survey on self-care attitudes has revealed. PAGB, the consumer healthcare association, surveyed over 2,000 adults across the UK about

    Read more